Innovative drug firms set up three sub-committees

The consultative body for 42 innovative drug firms, which belongs to the Korea Pharmaceutical Manufacturers Association (KPMA), held its first meeting last Friday to launch its three sub-committees named “Innovative R&D”, “Innovative Policy and Development” and “Public Relation Cooperation.”

Each sub-committee will have at least 14 member companies and launch operation based on its own busin...